Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra T Silverman

Showing results (101-110 of 236) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|June 12, 2013
Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1Stella Koutros, Dalsu Baris, Alexander Fischer, et al.
Epidemiology (Cambridge, Mass.)|September 2, 2017
Aspirin Use and Mortality in Two Contemporary US CohortsWen-Yi Huang, Sarah E Daugherty, Meredith S Shiels, et al.
ISRN Pathology|April 1, 2014
Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004Alan R Schned, Petra Lenz, Lee E Moore, et al.
Cancer Causes & Control : CCC|November 3, 2016
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) ProjectAmber N Wilcox, Debra T Silverman, Melissa C Friesen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 11, 2014
Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialSara H Olson, Meier Hsu, Joseph L Wiemels, et al.
Genes & Cancer|October 15, 2016
Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer developmentMeng Chen, Nathaniel Rothman, Yuanqing Ye, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?Cristiane Murta-Nascimento, Debra T Silverman, Manolis Kogevinas, et al.
Journal of the National Cancer Institute|August 1, 2025
Serum concentrations of per- and polyfluoroalkyl substances and risk of ovarian cancerRena R Jones, Jessica M Madrigal, Danielle N Medgyesi, et al.
Environmental Health Perspectives|April 22, 2025
Prediagnostic Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Endometrial Cancer in a US CohortJessica M Madrigal, Britton Trabert, Danielle N Medgyesi, et al.
Journal of the National Cancer Institute|October 31, 2012
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological studyAndré F S Amaral, Marinela Méndez-Pertuz, Alberto Muñoz, et al.
Pageof 24

Showing results (101-110 of 236) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|June 12, 2013
Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1Stella Koutros, Dalsu Baris, Alexander Fischer, et al.
Epidemiology (Cambridge, Mass.)|September 2, 2017
Aspirin Use and Mortality in Two Contemporary US CohortsWen-Yi Huang, Sarah E Daugherty, Meredith S Shiels, et al.
ISRN Pathology|April 1, 2014
Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004Alan R Schned, Petra Lenz, Lee E Moore, et al.
Cancer Causes & Control : CCC|November 3, 2016
Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) ProjectAmber N Wilcox, Debra T Silverman, Melissa C Friesen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 11, 2014
Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialSara H Olson, Meier Hsu, Joseph L Wiemels, et al.
Genes & Cancer|October 15, 2016
Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer developmentMeng Chen, Nathaniel Rothman, Yuanqing Ye, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?Cristiane Murta-Nascimento, Debra T Silverman, Manolis Kogevinas, et al.
Journal of the National Cancer Institute|August 1, 2025
Serum concentrations of per- and polyfluoroalkyl substances and risk of ovarian cancerRena R Jones, Jessica M Madrigal, Danielle N Medgyesi, et al.
Environmental Health Perspectives|April 22, 2025
Prediagnostic Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Endometrial Cancer in a US CohortJessica M Madrigal, Britton Trabert, Danielle N Medgyesi, et al.
Journal of the National Cancer Institute|October 31, 2012
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological studyAndré F S Amaral, Marinela Méndez-Pertuz, Alberto Muñoz, et al.
Pageof 24